Carriage of Colibactin-producing Bacteria and Colorectal Cancer Risk
- 1 November 2020
- journal article
- editorial
- Published by Elsevier in Trends in Microbiology
- Vol. 28 (11) , 874-876
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in ApcMin/+ MiceGastroenterology, 2020
- Mutational signature in colorectal cancer caused by genotoxic pks+ E. coliNature, 2020
- The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1BMC Gastroenterology, 2019
- Gut microbiome structure and metabolic activity in inflammatory bowel diseaseNature Microbiology, 2018
- Colibactin: More Than a New Bacterial ToxinToxins, 2018
- Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic ApproachesGastroenterology, 2017
- Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteriaGut, 2015
- Intestinal Inflammation Targets Cancer-Inducing Activity of the MicrobiotaScience, 2012
- Impaired Autophagy of an Intracellular Pathogen Induced by a Crohn's Disease Associated ATG16L1 VariantPLOS ONE, 2008
- Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic CellsScience, 2006